EARLY DRUG DISCOVERY

Prerequisites & course information

Requisites: Declared in Biotechnology MS Course Designation: Grad 50% - Counts toward 50% graduate coursework requirement Repeatable for Credit: No Last Taught: Fall 2026 Learning Outcomes: 1. Assess the early drug discovery process and key steps, from target identification to nonclinical trials. Audience: Graduate 2. Determine the scientific mechanism of one or more disease processes and assess how modulation of that target could treat or prevent a disease. Audience: Graduate 3. Compare current and emerging methods for generating compound diversity in chemical libraries, natural products, and antibodies, including molecular modeling and structure-based drug design. Audience: Graduate 4. Evaluate a technology used in drug discovery, understand the unmet need it addresses, and summarize the key information in a clear and concise way, both verbally and in a written format. Audience: Graduate Learning Outcomes: 1. Assess the early drug discovery process and key steps, from target identification to nonclinical trials. Audience: Graduate 2. Determine the scientific mechanism of one or more disease processes and assess how modulation of that target could treat or prevent a disease. Audience: Graduate 3. Compare current and emerging methods for generating compound diversity in chemical libraries, natural products, and antibodies, including molecular modeling and structure-based drug design. Audience: Graduate 4. Evaluate a technology used in drug discovery, understand the unmet need it addresses, and summarize the key information in a clear and concise way, both verbally and in a written format. Audience: Graduate